Raymond James & Associates »

Regeneron Pharmaceuticals shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $86M 82k 1051.24
2024-06-30 $78M 74k 1051.03
2024-03-31 $69M 71k 962.49
2023-12-31 $59M 67k 878.29
2023-09-30 $51M 62k 822.96
2023-06-30 $44M 62k 718.54
2023-03-31 $51M 62k 821.67
2022-12-31 $44M 61k 721.49
2022-09-30 $46M 67k 688.86
2022-06-30 $40M 68k 591.12
2022-03-31 $63M 90k 698.42
2021-12-31 $58M 92k 631.52
2021-09-30 $58M 96k 605.18
2021-06-30 $57M 101k 558.54
2021-03-31 $43M 91k 473.14
2020-12-31 $46M 95k 483.11
2020-09-30 $53M 94k 559.78
2020-06-30 $60M 97k 623.65
2020-03-31 $42M 86k 488.29
2019-12-31 $27M 72k 375.48
2019-09-30 $19M 69k 277.40
2019-06-30 $18M 57k 313.00
2019-03-31 $22M 54k 410.62
2018-12-31 $27M 72k 373.49
2018-09-30 $33M 82k 404.04
2018-06-30 $28M 82k 344.99
2018-03-31 $18M 52k 344.37
2017-12-31 $16M 41k 375.97
2017-09-30 $20M 45k 447.11
2017-06-30 $21M 42k 491.15
2017-03-31 $15M 39k 387.52
2016-12-31 $12M 32k 367.09
2016-09-30 $10M 25k 402.04
2016-06-30 $5.5M 16k 349.23
2016-03-31 $5.1M 14k 360.47
2015-12-31 $10M 19k 542.85
2015-09-30 $6.5M 14k 465.11
2015-06-30 $7.7M 15k 510.13